chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pemphigus; This spontaneous report from a contactable pharmacist reporting same event under the same suspect product for 6 patients. This is one of six reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pemphigus on an unspecified date with outcome of unknown. It was reported that while consulting her (reporter) dermatologist, she was informed that there are 6 patients who had pemphigus after receiving COVID vaccine.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021615652 Same reporter/drug/event, different patient;US-PFIZER INC-2021685995 Same reporter/drug/event, different patient;US-PFIZER INC-2021685959 Same reporter/drug/event, different patient;US-PFIZER INC-2021685997 Same reporter/drug/event, different patient;US-PFIZER INC-2021685996 Same reporter/drug/event, different patient
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with improperly stored M-M-R II (lot # L020188 and expiration date 03-JUN-2017, dose and route of administration were not reported). Concomitant therapy was not reported. The temperature of excursion was 13.3 Celsius degrees and the time frame was 11.25 hours cumulatively. It was stated that it was because of data logger. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Excess tearing, eye pain, shaky, felt hot.  Treatment:  Cold compress, supplemental oxygen via nasal cannula, and MD evaluation.
No other AE.; Patient received their first dose of GARDASIL 9 two years ago and has not received any additional doses since they received the first dose; This spontaneous report was received from a pharmacist referring to an adult patient of unknown gender. The patient's pertinent concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date in 2019 (reported as two years ago), at age of 42-year-old, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 dosage form as prophylaxis (concentration, route of administration, anatomical location, lot number and expiration date were not reported) however, did not received any additional doses since they received the first dose (inappropriate schedule of product administration). No adverse event was not reported.
PERICARDITIS; This spontaneous report received from a consumer via media via a company representative concerned a female of an unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 in total, dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced pericarditis. It was reported that, "My wife got pericarditis after the j and j jab". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pericarditis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20221149386-Pericarditis. The event has an unknown/unclear temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
Redness, warmth, swelling, rash and pain over site, pt has not been seen yet for reaction.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Severe, Systemic: Nausea-Mild
severe joint aches, sensitive skin, fatigue, headache, restlessness started Friday, February 4. On Friday evening/Saturday morning swollen glands on right side, severe right armpit pain, and sweating. Took Tylenol 2 times for armpit pain on Saturday. Fatigue and mild armpit pain persist today (Monday) but 90% relieved.
Arm soreness, Diarrhea, Headache, Nausea, and Fatigue. The last four were exact symptoms I had when I was ill with the virus. The side effects only lasted approximately 12 hours and most were alleviated with Zofran and Naproxen. No medication helped the headache, which was also my experience when I had the virus a month ago.
Immediate pain in upper arm upon injection. Trouble lifting arm and very painful in shoulder when lifting arm. Next few days were worse pain. Have had severe pain through today and numbness and burning in my shoulder area.
Pt presented to clinic 2 days, post vax, with large local reaction on the left thigh. Pt didn't appear to be in distress. Mom says he complained of itchiness at the site. As per doctor, advised her to use warm compresses and give Tylenol for discomfort. She's to follow-up if no improvement.
Immunization was giving sub-q instead of IM. Patient called three days later reporting site reaction of redness, but she did not seek medical attention and reaction was improving.
Tachycardia, chronic headache, widespread pain, digestive attacks, constipation, stomach pains, dizziness, nausea, decreased cognitive function, irregular menstruation, prolonged fatigue, anxiety, panic attacks, brain fog, syncope, delayed gastrointestinal emptying, cold hands and feet (always), insomnia,  memory impairment, blood pooling, out of work for several months, now working remotely with disability accommodation. I still have all of these symptoms daily, two years later. I am still seeking treatments, but have been through many treatments with the Clinic, POTS Treatment Center, Chronic Pain Clinics, Chronic Pain coaches, DNRS program. I am still trying to recover from this vaccine injury.
Situation Note: Called to see a 18 month old female for eval after WCC for possible allergic reaction after administration of vaccines. Both COVID-19 and Hepatitis A vaccine administered in right thigh. Right thigh after a few minutes +blotchy, patient scratching at it. After a few minutes, patient was sitting watching a video, and face started swelling. IM epinephrine given and EMS called. 5min after epi, rash on thigh and face swelling improved, EMS arrived.
Injection site is red and swollen. Advised pt to ice it to reduce swelling and watch to fever.
Sinus allergy infection in her head; Runny nose; Sneezing; Sore throat; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus allergy infection in her head), RHINORRHOEA (Runny nose), SNEEZING (Sneezing), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cardiac disorder.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus allergy infection in her head), RHINORRHOEA (Runny nose), SNEEZING (Sneezing), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). At the time of the report, SINUSITIS (Sinus allergy infection in her head) had not resolved and RHINORRHOEA (Runny nose), SNEEZING (Sneezing), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products used included high blood pressure and cardiac medicines.  Treatment medication included Coccidian for colds.  The patient had experienced similar symptoms for years. She was due to get her second dose of vaccine on 24-Mar-2021.
This spontaneous report was received from a Certified medical assistant and refers to an unspecified number of patients of unknown age and gender. Medical history and concomitant medications were unknown. It was reported that improperly stored doses of ROTATEQ Lot # K010221, expiry date 12-MAY-2016; Lot # K011952, expiry date 17-JUN-2016, oral route (dose was not reported), were given to unspecified patients on unspecified dates, between 22-JUL-2015 and 31-DEC-2015. No adverse effects were reported. No product quality complaint (PQC) was involved. It was also reported that GARDASIL 9 and PNEUMOVAX 23 were included on the list of questionable stability vaccines, but no doses were administered. This is one of three reports received from the same source. Additional information has been requested.
Reactions were from 2/16/2021, 3/9/2021 & 10/21/2021. The 10/21/2021 date is when  throat constriction occurred. The rest of the reactions were rash, hives or more common reactions.
Client    presented to the vaccination site on 11/04/21. The client notified RN  that she received a single dose of CanSino COVID vaccine on 4/30/21. RN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Janssen. Per CDC guidance, approval to proceed with COVID vaccine Janssen was obtained from medical consult team via text message from Vaccine Operations Lead . Client received COVID vaccine Janssen 11/04/21 Lot# 1855194. The client did not report any symptoms during the 15 minute observation period. RN educated client on possible adverse reactions and when to seek medical care
INFLAMMATION WAS SPREADING; Arm was heavy; Arm was hard; Arm was red; injection site has gotten itchy; injection site has gotten swollen; it is warm to the touch; Bruising; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (injection site has gotten itchy), INJECTION SITE SWELLING (injection site has gotten swollen), INJECTION SITE WARMTH (it is warm to the touch), CONTUSION (Bruising) and LIMB DISCOMFORT (Arm was heavy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided).    On 14-Jan-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced CONTUSION (Bruising). On 19-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection site has gotten itchy), INJECTION SITE SWELLING (injection site has gotten swollen), INJECTION SITE WARMTH (it is warm to the touch), LIMB DISCOMFORT (Arm was heavy), PERIPHERAL SWELLING (Arm was hard) and ERYTHEMA (Arm was red). On 20-Jan-2021, the patient experienced INFLAMMATION (INFLAMMATION WAS SPREADING). On 17-Jan-2021, CONTUSION (Bruising) outcome was unknown. At the time of the report, INJECTION SITE PRURITUS (injection site has gotten itchy), INJECTION SITE SWELLING (injection site has gotten swollen), INJECTION SITE WARMTH (it is warm to the touch), LIMB DISCOMFORT (Arm was heavy), PERIPHERAL SWELLING (Arm was hard), ERYTHEMA (Arm was red) and INFLAMMATION (INFLAMMATION WAS SPREADING) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: No specific follow-up information recorded. On 21-Jan-2021: No specific follow-up information recorded. On 27-Jan-2021: No specific follow-up information recorded.
pt had COVID booster on 7/13 and was seen in ER on 7/14 due to nausea, dyspnea, dizziness, wobbling gait, fever to 102.3 degrees.  Symptoms are improving but not resolved.  No longer fever, breathing is better, but she still feels a bit warm.  She recalls reactions to prior covid vaccines as well. She has history of prior COVID infection and subsequent PE during that illness.  She has had COVID 3-4 times.  She reports she also gets symptomatic from flu vaccinations with intense headaches and nausea. At the ER on 7/14 she had workup including labs which showed mildly elevated WBC of 12.3 with elevated neutrophils and otherwise not significant.  CTA of chest was negative for PE.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. No concomitant medications were provided.   Reporter did not allow further contact
A large, round, red inflamed area around the Afluria 2014-2015 infection site.  Very warm to the touch with an itching and burning sensation and the formation of dozens of tiny fluid filled blisters which cracked open upon scratching and then become crusty.
Fainted 13 hours after shot. Low-grade fever (up to 102) for 24 hours, chills, slight headache, loss of appetite, fatigue
Patient is experiencing marked swelling, with redness and heat at the injection site. Patient also has had nausea, blistering in the mouth and headache. Today she is feeling much better. Her Doctor's office suggested that she let us know about the reaction.
Hives on lower trunk; Vaccination site pain; Fatigue; Headache; Chills; Body aches; Fever 99.4; Nausea; General malaise; Brain fog; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled depression, anxiety, COVID-19 and mildly intolerant to gluten. Patient was allergic to ibuprofen (MOTRIN). Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) 15mg and ethinylestradiol, drospirenone (NIKKI); both from an unknown date and for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 20:00, the patient experienced hives on lower trunk and extremities continuing 96 hours after administered, injection site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 03Apr2021, the patient body temperature was measured and the result was 99.4 (units unspecified). The clinical outcome of the event hives on lower trunk, vaccination site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, swollen lymph nodes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
After the vaccine at 1PM I had a headache and then 4PM, Blood sugar was 300 and before was 100. Its still high and ongoing. It took a week after insulin that it came back to the normal. Did a phone visit with the doctor. The doctor said that its normal and it would be that way for 3 month.
felt sick; fever; Headache; Shortness of breath; Tiredness; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient). This female patient of unspecified age received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 27Mar2021 at single dose for COVID-19 immunization. Medical history was unknown. Concomitant medications included paracetamol (TYLENOL) and dextromethorphan hydrobromide/guaifenesin/paracetamol/pseudoephedrine hydrochloride (DAYQUIL). The patient received the 1st dose and after 2weeks, she felt sick. She had fever, headache, shortness of breath and tiredness. The patient took tylenol and dayquil. The 2nd dose schedule was on 17Apr2021 and she wanted to know if it's okay to receive it after she experienced adverse events. There were some unaddressed medical questions referred or forwarded to Medical Information. Outcome of the events was unknown.   The lot number has been requested.
CHEST PAIN, NUMBNESS IN ARMS AND LEGS, BREATHING PROBLEMS, HEADACHES
Onset of symptoms started with spots and was given Benadryl. Child continued to become listless with some airway compromise. Developed generalized urticaria with some significant wheals and blotchy redness that blanches with pressure.
Information has been received from the CDC concerning approximately 17 patients who were vaccinated with varicella virus vaccine live. Subsequently the patients experienced chickenpox. Additional patients (WAES01034333-01034335) also developed chickenpox following exposure to varicella virus vaccine live. No further information is available.
FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-JUL-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 08-JUL-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 08-JUL-2021. This report was non-serious.
3 days ago patient was started on Cipro for a UTI.  Patient received the ModernaCOVID vaccine 2 days ago.  The past 48 hours patient has had increased confusion, decreased p.o. intake. Patient was sent to emergency room for evaluation.  Patient was found to have a low sodium, 112, high potassium 6.9 with corresponding EKG changes.  Patient was bradycardic with a rate between 30 and 40.  Patient was also found to be in acute renal failure with a creatinine of 5.6.   In ER pt was confused, unable to tolerate PO fluids.  Due to severity of illness patient's family has elected to avoid aggressive medical care.  Patient has poor prognosis.  Patient was returned to nursing home for comfort care only.
Event: Blood clot in right leg (superficial thrombosis) Treatment: Rest, elevation, heat and ibuprofen  Outcomes: TBD
Patient received 2 bivalent pfizer boosters. First one was given on 10/28/22, second one was given on 12/31/22. Patient came by the pharmacy yesterday to get another booster as he self-reports as immunocompromised and travels frequently. He says his doctor advises him to get a vaccine before he travels. He has had no adverse events.
R lateral thigh dev. red, warm area, lot noticed 1-2 days post vaccine-on day 10 developed a 2cm red induration. Possible cellulitis, tx with Keflex 250mg tid x 7 days.
pt recv vax 2AUG96 & pt did not show seroconversion by negative IgG antibody;
I had few notable effects to the first 3 of the series. But, about 6 hours after receiving the second booster (4th dose) last week I sustained an outbreak of likely gout on my right big toe. I had a minor outbreak about 5 years ago that subsided after 2-3 days. The current outbreak coincided with the booster so it was worth reporting. Three days later the welt seems to be receding (drinking a lot of water and avoiding purine-rich foods). I don't anticipate any lasting effects.   It could be coincidence, but the coincidence is worth reporting to CDC.    Thank you.
the blood vessels are breaking; developed a rash; hives; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Jul2021 08:30 (Lot number: EWA70, Expiration Date: Aug2021) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "mastectomy" (unspecified if ongoing), notes: She had a mastectomy with her lymph nodes removed about a year ago; "lymph nodes removed" (unspecified if ongoing), notes: She had a mastectomy with her lymph nodes removed about a year ago. The patient's concomitant medications were not reported. The following information was reported: TELANGIECTASIA (non-serious) with onset 24Jul2021, outcome "not recovered", described as "the blood vessels are breaking"; RASH (non-serious) with onset 24Jul2021, outcome "not recovered", described as "developed a rash"; URTICARIA (non-serious) with onset 24Jul2021, outcome "not recovered", described as "hives". The events "the blood vessels are breaking", "developed a rash" and "hives" were evaluated at the emergency room visit.  Additional information: There was no additional vaccines administered on Same Date of the Pfizer vaccine. The patient did not receive any vaccine within four weeks prior to the first administration date of the suspect vaccine. There was no AE(s) following prior vaccinations. The patient medical history (including any illness at time of vaccination) was reported as none.  No follow-up attempts are possible. No further information is expected.
Adverse event: 36 hrs of Atrial Fibrillation.  BP157/107 HR 158 Treatment: Rx blood thinner (Eliquis) and beta blocker (Metoprolol) No further adverse event to second Pfizer Covid Vaccine dose Lot #EN6202 on 03/21/2021 while on prescribed treatment.  Ok now while on meds until appointment with cardiologist in May 2021  (FYI-My sister also had similar adverse reaction to Moderna 1st dose)